The subcellular distribution and function of MTA1 in cancer differentiation
Metrics: PDF 1746 views | HTML 1935 views | ?
Jian Liu1,2,*, Dongkui Xu3,*, Haijuan Wang1,*, Ying Zhang4, Yanan Chang4, Jinlong Zhang1, Jia Wang1, Chunxiao Li1, Huan Liu1, Mei Zhao1, Chen Lin1, Qimin Zhan1, Changzhi Huang1 and Haili Qian1
1 State Key Laboratory of Molecular Oncology; Cancer Institute/Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
2 Medical Research Center, Beijing ChaoYang Hospital, Capital Medical University, Beijing, China
3 Department of Abdominal Surgery, Cancer Institute/Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
4 Department of Gynecology Minimally Invasive Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
* These authors contribute equally to this work
Haili Qian, email:
Changzhi Huang, email:
Keywords: MTA1; Subcellular distribution; Cancer; Differentiation
Received: April 13, 2014 Accepted: June 10, 2014 Published: June 11, 2014
The functions and mechanisms of metastasis-associated protein 1 (MTA1) in cancer progression are still unclear due to a lagged recognition of the subcellular localization. In the present study, using multiple molecular technologies we confirmed for the first time that MTA1 localizes to the nucleus, cytoplasm and nuclear envelope. MTA1 is primarily localized in the nucleus of normal adult tissues but in the cytoplasm of embryonic tissues. While in colon cancer, both distributions have been described. Further investigation revealed that MTA1 localizes on the nuclear envelope in a translocated promoter region (TPR)-dependent manner, while in the cytoplasm, MTA1 shows an obvious localization on microtubules. Both nuclear and cytoplasmic MTA1 are associated with cancer progression. However, these functions may be associated with different mechanisms because only nuclear MTA1 has been associated with cancer differentiation. Overexpression of MTA1 in HCT116 cells inhibited differentiation and promoted proliferation, whereas MTA1 knockdown resulted in cell differentiation and death. Theses results not only suggest that nuclear MTA1 is a good marker for cancer differentiation diagnosis and a potential target for the treatment of cancers but also reveal the necessity to differentially examine the functions of nuclear and cytoplasmic MTA1.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.